COVID-19: Athlete Q&A / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021
The World Anti-Doping Agency (WADA) has published a new Question and Answer (Q&A) document for athletes related to anti-doping and COVID-19, which is an update to the last version that the Agency published on 25 May 2020.
The Q&A addresses matters such as the following -- reflecting the evolving nature of the pandemic; the changing testing environment; and, the fact that a growing number of Anti-Doping Organizations (ADOs) have resumed normal testing.
- Testing during COVID-19
- Minimizing the risk of contracting or transmitting the virus
- Filing of whereabouts information
- Validating Therapeutic Use Exemptions
- Maintaining the integrity of the global anti-doping system
- Impact of COVID-19 vaccines
- Confidence in the anti-doping system
The Q&A will continue to be updated to provide the latest information to athletes on how testing programs may evolve by integrating further health precautions to protect both clean sport and the health of athletes and sample collection personnel alike. WADA has also provided extensive guidance to ADOs, to ensure that testing is carried out in a secure manner, while respecting regional public health guidelines. The latest such document is the Agency’s ADO Guidance for Testing during COVID-19 Pandemic of 25 November 2020. Athletes who wish to know more about what specific measures their International Sport Federation (IF) or National Anti-Doping Organization (NADO) are taking in the face of this unprecedented challenge are encouraged to contact them directly.